Global Omega 3 Ingredients for Infant Food Market Insights, Forecast to 2028

Market Analysis and Insights: Global Omega 3 Ingredients for Infant Food Market
Due to the COVID-19 pandemic, the global Omega 3 Ingredients for Infant Food market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Marine Source accounting for % of the Omega 3 Ingredients for Infant Food global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Supplements and Functional Foods segment is altered to an % CAGR throughout this forecast period.
China Omega 3 Ingredients for Infant Food market size is valued at US$ million in 2021, while the US and Europe Omega 3 Ingredients for Infant Food are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Omega 3 Ingredients for Infant Food landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Omega 3 Ingredients for Infant Food include Aker BioMarine, Axellus, BASF, BioProcess Algae, EPAX, Martek Biosciences, Koninklijke DSM, Cargill Incorporated and Golden Omega, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Omega 3 Ingredients for Infant Food Scope and Segment
Omega 3 Ingredients for Infant Food market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Omega 3 Ingredients for Infant Food market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Marine Source
Plant Source

Segment by Application
Supplements and Functional Foods
Pharmaceuticals
Others

By Company
Aker BioMarine
Axellus
BASF
BioProcess Algae
EPAX
Martek Biosciences
Koninklijke DSM
Cargill Incorporated
Golden Omega
TASA
Lonza
Croda International
Clover Corporation
Pronova BioPharma
Omega Protein
FMC
Ocean Nutrition Canada
Arista Industries

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E